You have not enabled cookies! This site requires cookies to operate properly. Please enable cookies, and refresh your browser for full functionality.
News
FDA DELAYS RU-486 APPROVAL IN US
WASHINGTON, Feb 21 (LifeSiteNews) – On Friday, the US Food and Drug Administration withheld final approval for RU-486 as a number of questions remain unanswered. The Associated Press reports that the FDA wrote the pill’s marketing agent, Washington-based Danco Group, seeking answers on a number of undisclosed issues. See the LifeSite coverage of RU-486 in Spain. See the AP report.
WASHINGTON, Feb 21 (LifeSiteNews) – On Friday, the US Food and Drug Administration withheld final approval for RU-486 as a number of questions remain unanswered. The Associated Press reports that the FDA wrote the pill’s marketing agent, Washington-based Danco Group, seeking answers on a number of undisclosed issues.
